HIMS Stock Faces Dual Blow From Expanded FTC Privacy Lawsuit After Selloff Driven By Q3 Subscriber Loss

Shares of Hims & Hers Health (HIMS) continued to slide in after-hours trading on Tuesday as the telehealth provider faced fresh regulatory pressure on top of a disappointing earnings report released the day before.The Federal Trade Commission on Tuesday filed an amended complaint in the U.S. Distri…